We only have this paper's title and publication details.
Read it at the sourceResearch shows olaparib resistance in breast cancer by inhibiting methylation, suggesting new treatment pathways.
Supplementary Table S1: Target sequences of siRNAs and shRNAs
No takes yet. Share an insight, caveat, or question.
Qi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: